Angiotensin Receptor Blockers (ARBs) Market - Global Outlook and Forecast 2022-2028

Angiotensin Receptor Blockers (ARBs) Market - Global Outlook and Forecast 2022-2028

  • Market Monitor Global
  • January 2022
  • Pharmaceutical
  • 73 pages

Report Description

Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the reninangiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
This report contains market size and forecasts of Angiotensin Receptor Blockers (ARBs) in global, including the following market information:
Global Angiotensin Receptor Blockers (ARBs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiotensin Receptor Blockers (ARBs) Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Angiotensin Receptor Blockers (ARBs) companies in 2021 (%)
The global Angiotensin Receptor Blockers (ARBs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Valsartan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin Receptor Blockers (ARBs) include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Receptor Blockers (ARBs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin Receptor Blockers (ARBs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, by Type, 2021 (%)
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Global Angiotensin Receptor Blockers (ARBs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, by Application, 2021 (%)
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Global Angiotensin Receptor Blockers (ARBs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin Receptor Blockers (ARBs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiotensin Receptor Blockers (ARBs) revenues share in global market, 2021 (%)
Key companies Angiotensin Receptor Blockers (ARBs) sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Angiotensin Receptor Blockers (ARBs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Have query on this report?

Make an Enquiry
1 Introduction to Research & Analysis Reports
1.1 Angiotensin Receptor Blockers (ARBs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
List of Tables
Table 1. Key Players of Angiotensin Receptor Blockers (ARBs) in Global Market
Table 2. Top Angiotensin Receptor Blockers (ARBs) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Angiotensin Receptor Blockers (ARBs) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Companies, 2017-2022
Table 5. Global Angiotensin Receptor Blockers (ARBs) Sales by Companies, (K MT), 2017-2022

Success Stories

Our Clients